The golden age of Korean CEOs in multinational pharmaceutical companies

Published: 2015-09-04 13:20:23

Updated: 2015-09-04 13:20:23

A typical scene where a number of foreigners from headquarters are positioned in a Korean branch of a multinational pharmaceutical companies has been changing.

Recently, a proportion of Korean presidents in multinational pharmaceutical companies has increased.

Novartis Korea appointed President Hak-sun Moon, who used to take change in Novartis Taiwan, as a new president and CEO of Novartis Ko...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.